Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

[Leukopenia/neutropenia].

M J Bargetzi1

  • 1Zentrum für Onkologie/Hamatologie und Transfusionsmedizin, Kantonsspital Aarau. mario.bargetzi@ksa.ch

Therapeutische Umschau. Revue Therapeutique
|February 3, 2006
PubMed
Summary
This summary is machine-generated.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Efficient mobilization of PBSC with vinorelbine/G-CSF in patients with malignant lymphoma.

Bone marrow transplantation·2009
Same author

[Etiology and treatment of thrombocytopenia].

Therapeutische Umschau. Revue therapeutique·2004
Same author

[Cerebral metastasis in choriocarcinoma a case report].

Praxis·2003
Same author

Mobilization of peripheral blood progenitor cells with vinorelbine and granulocyte colony-stimulating factor in multiple myeloma patients is reliable and cost effective.

Bone marrow transplantation·2003
Same author

[Cervical tuberculous lymphadenopathy--a rare complication of myelodysplastic syndrome].

Praxis·2002
Same author

Successful treatment of paraneoplastic pemphigus in follicular NHL with rituximab: report of a case and review of treatment for paraneoplastic pemphigus in NHL and CLL.

American journal of hematology·2001
Same journal

[Multimodal Cardiac Imaging: New Developments for Clinical Practice].

Therapeutische Umschau. Revue therapeutique·2026
Same journal

[Coronary angiography: From cardiac catheterization to advanced interventional cardiovascular imaging].

Therapeutische Umschau. Revue therapeutique·2026
Same journal

[Athlete's heart: role of cardiac imaging in the prevention of sudden cardiac death].

Therapeutische Umschau. Revue therapeutique·2026
Same journal

[Multimodal imaging in cardiac amyloidosis and cardiac sarcoidosis].

Therapeutische Umschau. Revue therapeutique·2026
Same journal

[Inflammatory Heart Disease: The Role of Multimodality Cardiac Imaging in Myocarditis and Pericarditis].

Therapeutische Umschau. Revue therapeutique·2026
Same journal

State-of-the-Art Cardiac Imaging

Therapeutische Umschau. Revue therapeutique·2026
See all related articles

Evaluating leukopenia involves analyzing leukocyte subpopulations and cell morphology. Treatment focuses on the underlying systemic disease causing the low white blood cell count.

Area of Science:

  • Hematology
  • Clinical Pathology

Context:

  • Leukopenia, characterized by a decreased white blood cell count, requires careful evaluation.
  • Automated blood cell counts provide initial data on leukocyte subpopulations, erythrocytes, and platelets.
  • Microscopic examination of blood smears is crucial for verifying automated differentials and assessing cell morphology.

Purpose:

  • To outline the diagnostic approach for evaluating leukopenia.
  • To emphasize the importance of analyzing leukocyte subpopulations and cell morphology.
  • To highlight that leukopenia is often a sign of an underlying systemic disease.

Summary:

  • The initial step in leukopenia evaluation is analyzing leukocyte subpopulations using automated blood counts.
  • Microscopic blood smear analysis confirms automated differentials and evaluates cell morphology.

Related Experiment Videos

  • The differential diagnosis for leukopenia is broad, often indicating an epiphenomenon of systemic disease.

    • Impact:

    • Provides a clear diagnostic pathway for clinicians managing leukopenia.
    • Underscores the necessity of integrating automated counts with microscopic examination.
    • Reinforces the principle that effective leukopenia management requires addressing the root systemic cause.